Randomized controlled trials (RCTs), which is the gold-standard approach to extend indication of marketed drugs, have been limited by short follow-up periods and insufficient number of cases to detect the effect of GLP-1R agonists on ovarian cancer 15,16,17
As mentioned, at least some of these targets likely function in the GLD-1 pathway since a reduction of proteasome activity is synthetic tumorous with the loss of GLD-2 pathway genes
This inhibits osteoclast proliferation, differentiation, and bone resorption, raises bone mass, and may contribute to the prevention of OP (219)
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis
doi:10.1016/j.mehy.2020.110102 12
Risk factors for developing blood clots include having a history of DVT or pulmonary embolism, long periods of sitting or bed rest, such as during long flights or hospital stays, being overweight, having a family history of blood clots or clotting disorders, having inherited conditions like Factor V Leiden mutation, being over 60 years of age, or having diabetes
